Cite
APA Citation
Han, B., Zhang, B., Zhong, H., Shi, C., Gao, Z., Zhong, R., Gu, A., Chu, T., Wang, H., Xiong, L., Zhang, W., Zhang, X., Yan, B., Teng, J., Wang, W., Bai, H., Qiao, R., Cheng, L., & Kuang, Y. (n.d.). 134P Safety and efficacy of multi-target TKI combined with nivolumab in checkpoint inhibitor-refractory advanced NSCLC patients: A prospective, single arm, two stage study. Immuno-oncology technology, 16, . http://access.bl.uk/ark:/81055/vdc_100172069101.0x000007